Jersey Shore Medical Center Addiction Recovery Services is a mental health and substance abuse treatment facility located at 1200 Jumping Brook Road, Building 5 in the 07753 zip code in Neptune, NJ.
It is operated by a private non-profit organization. Jersey Shore Medical Center Addiction Recovery Services provides relapse prevention from naltrexone, administers naltrexone and prescribes suboxone. Some of the treatment approaches used by Jersey Shore Medical Center Addiction Recovery Services include motivational interviewing, dialectical behavior therapy and matrix model. Jersey Shore Medical Center Addiction Recovery Services provides outpatient treatment, intensive outpatient treatment services and regular outpatient treatment. It also provides residential substance use treatment and inpatient dual diagnosis treatment.
Here are the full facility listing details on Jersey Shore Medical Center Addiction Recovery Services in Neptune, NJ:
Types of Care:
- residential substance abuse treatment
- inpatient treatment for co-occurring mental health and substance use disorders
Service Settings:
- outpatient treatment
- intensive outpatient treatment
- outpatient methadone/buprenorphine or naltrexone treatment
- regular outpatient treatment
Hospitals:
- General Hospital (including VA hospital)
Opioid Medications used in Treatment:
- Buprenorphine clinical treatment
- Naltrexone treatment
External Opioid Medications Source:
- In-network prescribing entity
- Personal physician/health care provider
Type of Alcohol Use Disorder Treatment:
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- Administers medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment:
- In-network prescribing entity
- Personal physician/health care provider
Type Of Treatment:
- buprenorphine maintenance
- prescribes suboxone
- naltrexone administration
- relapse prevention from naltrexone
Pharmacotherapies:
- Acamprosate (Campral)
- Disulfiram (Antabuse)
- Buprenorphine with naloxone (Ex. Suboxone)
- Buprenorphine without naloxone
- Naltrexone (oral)
- Naltrexone (extended-release, injectable naltrexone - Vivitrol)
- Medications for psychiatric disorders
Treatment Approaches:
- brief intervention
- cognitive behavioral therapy
- DBT
- motivational interviewing
- matrix model
- relapse prevention
- substance use counseling approach
- counseling for trauma victims
- 12 step rehabilitation
Facility Ownership:
- a private non-profit organization
License/Certification/Accreditation:
- State substance abuse agency
- State department of health
- State mental health department
- Certified by The Joint Commission
Payment/Insurance/Funding Accepted:
- Accepts Federal funding
- Accepts Medicare
- Accepts Medicaid
- Accepts Military insurance
- Accepts private health insurance
- Accepts cash
- Accepts state health insurance
Payment Assistance Available:
Special Programs/ Population Groups Supported:
- co-occurring addiction and mental health treatment
Assessment/Pre-treatment:
- Comprehensive mental health assessment
- Comprehensive substance use assessment
Screening & Testing:
- Breathalyzer or blood alcohol testing
- Drug or alcohol urine screening
- Screening for mental disorders
- Screening for substance use
- Testing for metabolic syndrome
Transitional Services:
- Aftercare/continuing care
- Discharge Planning
- Naloxone and overdose education
Ancillary Services:
- case management
- mental health services
- social skills development
- transportation assistance
Counseling Services and Education:
- individual counseling services
- counseling for groups
- counseling for families
- counseling for couples
- substance use education
- health education services
Tobacco/Screening Services:
- Screening for tobacco use
- Smoking/tobacco cessation counseling
Facility Smoking Policy:
Age Groups Accepted:
- adult rehab
- accepts young adults over 18
Gender Accepted:
Services for deaf:
- Service for hearing impaired
Call (888) 303-2026 to get 24/7 help with treatment.
SPONSORED AD
